- Home
- ROOT vs BLFS Comparison
ROOT vs BLFS Comparison
Compare ROOT & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROOT
- BLFS
- Stock Information
- Founded
- ROOT 2015
- BLFS 1987
- Country
- ROOT United States
- BLFS United States
- Employees
- ROOT N/A
- BLFS N/A
- Industry
- ROOT Property-Casualty Insurers
- BLFS Medical/Dental Instruments
- Sector
- ROOT Finance
- BLFS Health Care
- Exchange
- ROOT Nasdaq
- BLFS Nasdaq
- Market Cap
- ROOT 1.2B
- BLFS 1.3B
- IPO Year
- ROOT 2020
- BLFS 1989
- Fundamental
- Price
- ROOT $88.82
- BLFS $27.57
- Analyst Decision
- ROOT Buy
- BLFS Strong Buy
- Analyst Count
- ROOT 6
- BLFS 7
- Target Price
- ROOT $124.40
- BLFS $30.86
- AVG Volume (30 Days)
- ROOT 489.5K
- BLFS 349.3K
- Earning Date
- ROOT 11-05-2025
- BLFS 11-06-2025
- Dividend Yield
- ROOT N/A
- BLFS N/A
- EPS Growth
- ROOT N/A
- BLFS N/A
- EPS
- ROOT 3.34
- BLFS N/A
- Revenue
- ROOT $1,446,800,000.00
- BLFS $93,468,000.00
- Revenue This Year
- ROOT $27.41
- BLFS $25.65
- Revenue Next Year
- ROOT $9.74
- BLFS $14.81
- P/E Ratio
- ROOT $26.57
- BLFS N/A
- Revenue Growth
- ROOT 38.50
- BLFS 68.16
- 52 Week Low
- ROOT $68.48
- BLFS $19.10
- 52 Week High
- ROOT $181.14
- BLFS $29.62
- Technical
- Relative Strength Index (RSI)
- ROOT 58.91
- BLFS 52.62
- Support Level
- ROOT $77.50
- BLFS $26.43
- Resistance Level
- ROOT $82.50
- BLFS $28.21
- Average True Range (ATR)
- ROOT 3.95
- BLFS 1.04
- MACD
- ROOT 1.38
- BLFS -0.15
- Stochastic Oscillator
- ROOT 91.11
- BLFS 36.31
About ROOT Root Inc.
Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. It generates revenue from the sales of auto insurance policies within the United States.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.